SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 331 filers reported holding SAREPTA THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 1.02 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $5,000 | -88.9% | 70 | -87.7% | 0.00% | -87.5% |
| Q1 2022 | $45,000 | -11.8% | 570 | 0.0% | 0.01% | 0.0% |
| Q4 2021 | $51,000 | -48.5% | 570 | -46.7% | 0.01% | -55.6% |
| Q3 2021 | $99,000 | +19.3% | 1,070 | 0.0% | 0.02% | +20.0% |
| Q2 2021 | $83,000 | +3.8% | 1,070 | 0.0% | 0.02% | -16.7% |
| Q1 2021 | $80,000 | -18.4% | 1,070 | +85.8% | 0.02% | -28.0% |
| Q4 2020 | $98,000 | +60.7% | 576 | +32.1% | 0.02% | +25.0% |
| Q3 2020 | $61,000 | +60.5% | 436 | +84.7% | 0.02% | +33.3% |
| Q2 2020 | $38,000 | +81.0% | 236 | +11.8% | 0.02% | +50.0% |
| Q1 2020 | $21,000 | +50.0% | 211 | +99.1% | 0.01% | +100.0% |
| Q4 2019 | $14,000 | +75.0% | 106 | 0.0% | 0.01% | +25.0% |
| Q3 2019 | $8,000 | -50.0% | 106 | 0.0% | 0.00% | -42.9% |
| Q2 2019 | $16,000 | +1500.0% | 106 | +1666.7% | 0.01% | +600.0% |
| Q1 2019 | $1,000 | – | 6 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ghost Tree Capital, LLC | 290,000 | $44,066,000 | 9.14% |
| Avoro Capital Advisors LLC | 1,400,000 | $212,730,000 | 7.35% |
| NEXTHERA CAPITAL LP | 50,317 | $7,646,000 | 6.37% |
| Eventide Asset Management | 1,123,000 | $170,640,000 | 5.19% |
| RTW INVESTMENTS, LP | 604,236 | $91,814,000 | 4.90% |
| Casdin Capital, LLC | 335,000 | $50,903,250,000 | 4.76% |
| Copernicus Capital Management, LLC | 30,000 | $4,559,000 | 4.06% |
| CADIAN CAPITAL MANAGEMENT, LP | 548,500 | $83,345,000 | 3.76% |
| Dynamic Capital Management Ltd | 4,677 | $711,000 | 3.54% |
| Camber Capital Management LP | 500,000 | $75,975,000 | 3.54% |